GLYXAMBI is a prescription medicine that contains 2 diabetes medicines, empagliflozin (JARDIANCE). If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.
GLYXAMBI is a prescription medicine that contains 2 diabetes medicines, empagliflozin (JARDIANCE) and linagliptin (TRADJENTA) GLYXAMBI can be used along with diet and exercise to lower blood sugar in adults with type 2 diabetes when treatment with both empagliflozin (JARDIANCE) and linagliptin (TRADJENTA) is appropriate.
GLYXAMBI is not for people with type 1 diabetes.
GLYXAMBI is not for people with diabetic ketoacidosis (increased ketones in the blood or urine).
If you have had pancreatitis in the past, it is not known if you have a higher chance of getting pancreatitis while you take GLYXAMBI.
Glyxambi (empagliflozin) suppliers in India. Allevaire India Network New Delhi, INDIA.
Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.
The order for Glyxambi (empagliflozin) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
GLYXAMBI tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate.
Limitation of Use:
GLYXAMBI is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.
GLYXAMBI has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using GLYXAMBI.
Medicine Name: Glyxambi
Generic Name: Empagliflozin
Approval Date: 8, 2014
Company Name: Boehringer Ingelheim International GmbH.
Available as (Form & Strength): Tablets: 10 mg empagliflozin/5 mg linagliptin and 25 mg empagliflozin/5 mg linagliptin
Glyxambi (Empagliflozin) is available.
Get In Touch
ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Glyxambi (empagliflozin) on prescription and Import License in Patient’s Name only.
For foreign countries patients, Glyxambi (empagliflozin) can be made available in Send your enquiry to find Glyxambi (empagliflozin) in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Glyxambi (empagliflozin) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details